Yasemin Topcu
Yasemin Topcu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Erhan Bayram
Division of Pediatric Neurology, Dokuz Eylul University Hospital, Izmir, Turkey
6 shared publicationsPakize Karaoglu
Department of Pediatrics, Division of Pediatric Neurology, Dokuz Eylul University Medical Faculty, Izmir, Turkey
4 shared publicationsSemraHiz Kurul
Department of Pediatrics, Division of Pediatric Neurology, Dokuz Eylul University Medical Faculty, Izmir, Turkey
4 shared publicationsUluc Yis
Division of Pediatric Neurology, Dokuz Eylul University Hospital, Izmir, Turkey
4 shared publications- Uluç Yiş
Dokuz Eylul University Children's Hospital, Department of Pediatric Neurology, Izmir, Turkey
4 shared publications - Erhan Bayram
Department of Pediatric Neurology, Dokuz Eylul University, Faculty of Medicine, İzmir, Narlıdere, Turkey
3 shared publications
Latest Publications
- 23 September 2014
- Published by Wiley in Acta Paediatrica
- Vol. 103 (11) , e484-e489
The Paediatric migraine disability assessment score is a useful tool for evaluating prophylactic migraine treatment
Aim: There is a need for an objective assessment scoring system to evaluate the effectiveness of prophylactic drugs in paediatric migraine, and the aim of this study was to evaluate the Paediatric Migraine Disability Assessment Score (PedMIDAS).Methods: We recruited 88 children aged between 6 and 17 years of age with migraine. The 53 children in the treatment group were divided into three groups according to the prophylactic drug they received topiramate, flunarizine and propranolol and assessed using PedMIDAS before the start of treatment and 3 and 6 months after treatment. The 35 patients in the control group did not receive prophylactic treatment and were assessed with PedMIDAS on three occasions, 3 months apart.Results: Topiramate, propranolol and flunarizine treatments significantly decreased PedMIDASs and were shown to be effective in improving the patients’ quality of life. Topiramate and propranolol were more effective than flunarizine. The number of days on analgesic treatment significantly decreased in the patients who had received topiramate and propranolol treatments (p < 0.05), but remained unchanged in the flunarizine prophylaxis group (p > 0.05).Conclusion: The PedMIDAS scoring system is useful in evaluating the efficacy of prophylactic therapy in paediatric migraine. Topiramate and propranolol lowered the PedMIDASs better than flunarizine.
- 23 September 2014
- Published by Wiley in Acta Paediatrica
- Vol. 103 (11) , e484-e489
The Paediatric migraine disability assessment score is a useful tool for evaluating prophylactic migraine treatment
Aim: There is a need for an objective assessment scoring system to evaluate the effectiveness of prophylactic drugs in paediatric migraine, and the aim of this study was to evaluate the Paediatric Migraine Disability Assessment Score (PedMIDAS).Methods: We recruited 88 children aged between 6 and 17 years of age with migraine. The 53 children in the treatment group were divided into three groups according to the prophylactic drug they received topiramate, flunarizine and propranolol and assessed using PedMIDAS before the start of treatment and 3 and 6 months after treatment. The 35 patients in the control group did not receive prophylactic treatment and were assessed with PedMIDAS on three occasions, 3 months apart.Results: Topiramate, propranolol and flunarizine treatments significantly decreased PedMIDASs and were shown to be effective in improving the patients’ quality of life. Topiramate and propranolol were more effective than flunarizine. The number of days on analgesic treatment significantly decreased in the patients who had received topiramate and propranolol treatments (p < 0.05), but remained unchanged in the flunarizine prophylaxis group (p > 0.05).Conclusion: The PedMIDAS scoring system is useful in evaluating the efficacy of prophylactic therapy in paediatric migraine. Topiramate and propranolol lowered the PedMIDASs better than flunarizine.
- 11 June 2014
- Published by Springer Nature in Neurological Sciences
- Vol. 35 (11) , 1769-1775
Zonisamide attenuates hyperoxia-induced apoptosis in the developing rat brain
Oxygen therapy used in the treatment of perinatal hypoxia induces neurodegeneration in babies with immature antioxidant mechanisms. Zonisamide is a new antiepileptic drug used in childhood intractable seizures. Many studies demonstrated its neuroprotective effects. There is no study evaluating its effect on hyperoxic brain injury. The aim of this study was to investigate the neuroprotective effect of zonisamide on hyperoxia-induced neonatal brain injury. A total of 21 Wistar rat pups were used. The animals were divided into three groups: control group, hyperoxia group, and zonisamide-treated group. The zonisamide-treated group received an intraperitoneal injection of zonisamide. Zonisamide significantly preserved the number of neurons in CA1 and dentate gyrus parts of hippocampus, prefrontal, and parietal cortex. Zonisamide treatment also decreased the number of apoptotic neurons in all examined parts of hippocampus, prefrontal, and parietal cortex. We suggest that zonisamide treatment may be used as a neuroprotective agent in hyperoxic brain injury.
- 11 June 2014
- Published by Springer Nature in Neurological Sciences
- Vol. 35 (11) , 1769-1775
Zonisamide attenuates hyperoxia-induced apoptosis in the developing rat brain
Oxygen therapy used in the treatment of perinatal hypoxia induces neurodegeneration in babies with immature antioxidant mechanisms. Zonisamide is a new antiepileptic drug used in childhood intractable seizures. Many studies demonstrated its neuroprotective effects. There is no study evaluating its effect on hyperoxic brain injury. The aim of this study was to investigate the neuroprotective effect of zonisamide on hyperoxia-induced neonatal brain injury. A total of 21 Wistar rat pups were used. The animals were divided into three groups: control group, hyperoxia group, and zonisamide-treated group. The zonisamide-treated group received an intraperitoneal injection of zonisamide. Zonisamide significantly preserved the number of neurons in CA1 and dentate gyrus parts of hippocampus, prefrontal, and parietal cortex. Zonisamide treatment also decreased the number of apoptotic neurons in all examined parts of hippocampus, prefrontal, and parietal cortex. We suggest that zonisamide treatment may be used as a neuroprotective agent in hyperoxic brain injury.
- 12 February 2014
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 50 (7) , 553-556
The efficacy and safety of levetiracetam in paediatric patients treated with chemotherapeutic agents for haematologic disorders
- 12 February 2014
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 50 (7) , 553-556
The efficacy and safety of levetiracetam in paediatric patients treated with chemotherapeutic agents for haematologic disorders
- Open Access
- 1 January 2014
- Published by Medknow in Annals of Indian Academy of Neurology
- Vol. 17 (4) , 437-40
Importance of acylcarnitine profile analysis for disorders of lipid metabolism in adolescent patients with recurrent rhabdomyolysis: Report of two cases
Metabolic myopathies due to disorders of lipid metabolism are a heterogeneous group of diseases. Newborns may present with hypotonia and convulsions, while progressive proximal muscle weakness or recurrent episodes of muscle weakness accompanied by rhabdomyolysis/myoglobinuria may be seen in older ages. There is little knowledge on detection of disorders of lipid metabolism by acylcarnitine profile (ACP) analysis by tandem mass spectrometry outside the neonatal period particularly in cases with recurrent rhabdomyolysis first presenting in adolescence and adulthood. Two adolescent female cases presented with episodes of rhabdomyolysis and muscle weakness. A 13-year-old patient had five episodes of rhabdomyolysis triggered by infections. Tandem mass spectrometry was normal. A 16-year-old female patient was hospitalized eight times due to recurrent rhabdomyolysis. Increased levels of C14:2, C14:1, and C14 were determined in tandem mass spectrometry. Final diagnoses were carnitine palmitoyltransferase II (CPT II) deficiency and very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. Increased serum levels of long-chain acylcarnitine can guide to the diagnosis of lipid metabolism disorders. Serum ACP should be performed before enzyme assay and genetic studies.
- 1 January 2014
- Published by Medknow in Annals of Indian Academy of Neurology
- Vol. 17 (4) , 437-40
Open AccessImportance of acylcarnitine profile analysis for disorders of lipid metabolism in adolescent patients with recurrent rhabdomyolysis: Report of two cases
Metabolic myopathies due to disorders of lipid metabolism are a heterogeneous group of diseases. Newborns may present with hypotonia and convulsions, while progressive proximal muscle weakness or recurrent episodes of muscle weakness accompanied by rhabdomyolysis/myoglobinuria may be seen in older ages. There is little knowledge on detection of disorders of lipid metabolism by acylcarnitine profile (ACP) analysis by tandem mass spectrometry outside the neonatal period particularly in cases with recurrent rhabdomyolysis first presenting in adolescence and adulthood. Two adolescent female cases presented with episodes of rhabdomyolysis and muscle weakness. A 13-year-old patient had five episodes of rhabdomyolysis triggered by infections. Tandem mass spectrometry was normal. A 16-year-old female patient was hospitalized eight times due to recurrent rhabdomyolysis. Increased levels of C14:2, C14:1, and C14 were determined in tandem mass spectrometry. Final diagnoses were carnitine palmitoyltransferase II (CPT II) deficiency and very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. Increased serum levels of long-chain acylcarnitine can guide to the diagnosis of lipid metabolism disorders. Serum ACP should be performed before enzyme assay and genetic studies.
- 7 November 2013
- Vol. 55 (2) , 235-6
A case of atypical Miller Fisher syndrome with negative anti-GQ1b immunoglobulin G and importance of H reflex.
- 7 November 2013
- Vol. 55 (2) , 235-6
A case of atypical Miller Fisher syndrome with negative anti-GQ1b immunoglobulin G and importance of H reflex.
- 25 July 2013
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 45 (01) , 030-035
Comparison of Cranial Magnetic Resonance Imaging Findings and Clinical Features in Patients with Corpus Callosum Abnormalities
Aim The aim of this study was to evaluate the relationship between clinical and cranial magnetic resonance imaging findings in patients with corpus callosum (CC) abnormalities. Patients and Methods Between September 2010 and March 2012, patients with developmental CC abnormalities were included in the study. CC abnormalities were classified as total agenesis, partial agenesis, and callosal hypoplasia. Regarding the groups, the association between radiological abnormalities and clinical findings were evaluated. Results A total of 62 patients (32 females [51.6%] and 30 males [48.4%]) with a mean age of 18.0 ± 32.1 months were enrolled in the study. Of them, 20 patients (32.3%) had total agenesis, 9 patients (14.5%) had partial agenesis, and 33 (53.2%) patients had hypoplasia of the CC. Thirty-five cases (56.7%) had abnormal physical examination, 47 cases (75.8%) had abnormal neurological examination, and 42 cases (67.7%) had psychomotor retardation. There were no significant differences between groups regarding physical examination, psychomotor retardation, seizures, or microcephaly. Seizures, psychomotor retardation, and neurological abnormalities were significantly more frequent in patients with associated other radiological abnormalities. Posterior segment of the CC was significantly thinner in patients with psychomotor retardation and the anterior part of the CC thinner in patients with abnormal physical examination. Patients with total agenesis were more prone to seizures at an early age than patients with partial agenesis or hypoplasia. Conclusion The neurological prognosis of patients with CC abnormalities is poorer in patients with an associated neuroradiological abnormality. Early development of seizures may be observed in cases with total agenesis of the CC.
- 25 July 2013
- Published by Georg Thieme Verlag KG in Neuropediatrics
- Vol. 45 (01) , 030-035
Comparison of Cranial Magnetic Resonance Imaging Findings and Clinical Features in Patients with Corpus Callosum Abnormalities
Aim The aim of this study was to evaluate the relationship between clinical and cranial magnetic resonance imaging findings in patients with corpus callosum (CC) abnormalities. Patients and Methods Between September 2010 and March 2012, patients with developmental CC abnormalities were included in the study. CC abnormalities were classified as total agenesis, partial agenesis, and callosal hypoplasia. Regarding the groups, the association between radiological abnormalities and clinical findings were evaluated. Results A total of 62 patients (32 females [51.6%] and 30 males [48.4%]) with a mean age of 18.0 ± 32.1 months were enrolled in the study. Of them, 20 patients (32.3%) had total agenesis, 9 patients (14.5%) had partial agenesis, and 33 (53.2%) patients had hypoplasia of the CC. Thirty-five cases (56.7%) had abnormal physical examination, 47 cases (75.8%) had abnormal neurological examination, and 42 cases (67.7%) had psychomotor retardation. There were no significant differences between groups regarding physical examination, psychomotor retardation, seizures, or microcephaly. Seizures, psychomotor retardation, and neurological abnormalities were significantly more frequent in patients with associated other radiological abnormalities. Posterior segment of the CC was significantly thinner in patients with psychomotor retardation and the anterior part of the CC thinner in patients with abnormal physical examination. Patients with total agenesis were more prone to seizures at an early age than patients with partial agenesis or hypoplasia. Conclusion The neurological prognosis of patients with CC abnormalities is poorer in patients with an associated neuroradiological abnormality. Early development of seizures may be observed in cases with total agenesis of the CC.
- Open Access
- 1 January 2013
- Published by Medknow in Annals of Indian Academy of Neurology
- Vol. 16 (4) , 716-9
The combination of thermal dysregulation and agenesis of corpus callosum: Shapiro′s or/and reverse Shapiro′s syndrome
Shapiro syndrome is an extremely rare condition consisting the clinical triad of recurrent hypothermia, hyperhydrosis and agenesis of the corpus callosum. On the other hand, reverse Shapiro's sydrome is characterized periodic hyperthermia and agenesis of the corpus callosum. Here, we describe a 3.5-year-old girl with complete agenesis of corpus callosum presenting with recurrent fever and vomiting. She also had hypothermia attacks with accompanying diaphoresis. To the best of our knowledge, there is no described case with episodes of hyperthermia, hypothermia, and vomiting associated with agenesis of the corpus callosum. Recurrent vomiting may be a newly defined symptom associated with these syndromes.
- 1 January 2013
- Published by Medknow in Annals of Indian Academy of Neurology
- Vol. 16 (4) , 716-9
Open AccessThe combination of thermal dysregulation and agenesis of corpus callosum: Shapiro′s or/and reverse Shapiro′s syndrome
Shapiro syndrome is an extremely rare condition consisting the clinical triad of recurrent hypothermia, hyperhydrosis and agenesis of the corpus callosum. On the other hand, reverse Shapiro's sydrome is characterized periodic hyperthermia and agenesis of the corpus callosum. Here, we describe a 3.5-year-old girl with complete agenesis of corpus callosum presenting with recurrent fever and vomiting. She also had hypothermia attacks with accompanying diaphoresis. To the best of our knowledge, there is no described case with episodes of hyperthermia, hypothermia, and vomiting associated with agenesis of the corpus callosum. Recurrent vomiting may be a newly defined symptom associated with these syndromes.
- Open Access
- 1 January 2013
- Published by Medknow in Journal of Pediatric Neurosciences
- Vol. 8 (3) , 259-60
Kabuki syndrome and perisylvian cortical dysplasia in a Turkish girl
The official publication of the Indian Society of Pediatric Neurosurgeons
- 1 January 2013
- Published by Medknow in Journal of Pediatric Neurosciences
- Vol. 8 (3) , 259-60
Open AccessKabuki syndrome and perisylvian cortical dysplasia in a Turkish girl
The official publication of the Indian Society of Pediatric Neurosurgeons
- Open Access
- 1 January 2013
- Published by Medknow in Journal of Pediatric Neurosciences
- Vol. 8 (1) , 59-63
Coexistence of myositis, transverse myelitis, and Guillain Barré syndrome following Mycoplasma pneumoniae infection in an adolescent
Guillain-Barré syndrome (GBS) and transverse myelitis may occur coexistently in the pediatric population. This may be explained by a shared epitope between peripheral and central nervous system myelin. Coexistent transverse myelitis, myositis, and acute motor neuropathy in childhood have not been previously described. We describe a 14-year-old female patient with transverse myelitis, myositis, and GBS following Mycoplasma pneumoniae infection. She presented with weakness and walking disability. Weakness progressed to involve all extremities and ultimately, she was unable to stand and sit. Based on the clinical findings, a presumptive diagnosis of myositis was made at an outside institution because of high serum creatine kinase level. The patient was referred to our institution for further investigation. Magnetic resonance imaging of spine revealed enhancing hyperintense lesions in the anterior cervicothoracic spinal cord. The electromyography revealed acute motor polyneuropathy. Serum M. pneumoniae IgM and IgG were positive indicating an acute infection. Repeated M. pneumoniae serology showed a significant increase in Mycoplasma IgG titer. The patient was given intravenous immunoglobulin for 2 days and clarithromycin for 2 weeks. She was able to walk without support after 2 weeks of hospitalization. This paper emphasizes the rarity of concomitant myositis, transverse myelitis, and GBS in children.
- 1 January 2013
- Published by Medknow in Journal of Pediatric Neurosciences
- Vol. 8 (1) , 59-63
Open AccessCoexistence of myositis, transverse myelitis, and Guillain Barré syndrome following Mycoplasma pneumoniae infection in an adolescent
Guillain-Barré syndrome (GBS) and transverse myelitis may occur coexistently in the pediatric population. This may be explained by a shared epitope between peripheral and central nervous system myelin. Coexistent transverse myelitis, myositis, and acute motor neuropathy in childhood have not been previously described. We describe a 14-year-old female patient with transverse myelitis, myositis, and GBS following Mycoplasma pneumoniae infection. She presented with weakness and walking disability. Weakness progressed to involve all extremities and ultimately, she was unable to stand and sit. Based on the clinical findings, a presumptive diagnosis of myositis was made at an outside institution because of high serum creatine kinase level. The patient was referred to our institution for further investigation. Magnetic resonance imaging of spine revealed enhancing hyperintense lesions in the anterior cervicothoracic spinal cord. The electromyography revealed acute motor polyneuropathy. Serum M. pneumoniae IgM and IgG were positive indicating an acute infection. Repeated M. pneumoniae serology showed a significant increase in Mycoplasma IgG titer. The patient was given intravenous immunoglobulin for 2 days and clarithromycin for 2 weeks. She was able to walk without support after 2 weeks of hospitalization. This paper emphasizes the rarity of concomitant myositis, transverse myelitis, and GBS in children.
- Open Access
- 11 September 2012
- Published by Modestum Ltd in Journal of Clinical and Experimental Investigations
- Vol. 3 (3)
Long term neurodevelopmental outcome of preterm infants with periventricularintraventricular hemorrhage
- 11 September 2012
- Published by Modestum Ltd in Journal of Clinical and Experimental Investigations
- Vol. 3 (3)
Open AccessLong term neurodevelopmental outcome of preterm infants with periventricularintraventricular hemorrhage